Countries citing papers authored by Peter B. Meier
Since
Specialization
Citations
This map shows the geographic impact of Peter B. Meier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter B. Meier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter B. Meier more than expected).
This network shows the impact of papers produced by Peter B. Meier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter B. Meier. The network helps show where Peter B. Meier may publish in the future.
Co-authorship network of co-authors of Peter B. Meier
This figure shows the co-authorship network connecting the top 25 collaborators of Peter B. Meier.
A scholar is included among the top collaborators of Peter B. Meier based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Peter B. Meier. Peter B. Meier is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
George, Stephanie M., John Crowley, S S Ellenberg, et al.. (1993). Discussion: Stephen George, a survey of monitoring practices in cancer clinical trials: Stephanie Green and John Crowley, data monitoring committees for Southwest Oncology Group clinical trials. Statistics in Medicine. 12. 457–459.2 indexed citations
8.
Rockhold, Frank W., Gregory G. Enas, Peter B. Meier, et al.. (1993). Discussion: Frank W Rockhold and G Enas, data monitoring and interim analyses in the pharmaceutical industry: Ethical and logistical considerations: George W Williams et al, monitoring of clinical trials and interim analyses from a drug sponsor's point of view. Statistics in Medicine. 12. 493–495.1 indexed citations
9.
Parmar, Mkb, David Machín, Joseph L. Pater, et al.. (1993). Discussion: M K B Parmar and David Machin, monitoring clinical trials; Experience of, and proposals under consideration by the Cancer Therapy Committee of the British Medical Research Council.1 indexed citations
10.
Shaw, Michael J., Martin L. Freeman, Peter B. Meier, et al.. (1993). Results of a multicenter trial using a mechanical lithotripter for the treatment of large bile duct stones.. PubMed. 88(5). 730–3.59 indexed citations
11.
Meier, Peter B.. (1991). Book Review. Gastrointestinal Endoscopy. 37(4). 507–508.4 indexed citations
12.
Meier, Peter B., M. Schmid, & M Stäubli. (1990). [Acute hepatitis following administration of fansidar].. PubMed. 120(7). 221–5.4 indexed citations
Meier, Peter B., Michael S. Huber, Jeffery L. Meier, Marko Turina, & Marianne Schmid. (1987). [Aorto-esophageal fistula: late complications following aortic graft implantation].. PubMed. 117(29). 1104–8.2 indexed citations
17.
Meier, Peter B. & Michael D. Levitt. (1986). Urine protein excretion in acute pancreatitis.. PubMed. 108(6). 628–34.11 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.